DE69622148T2 - Chinazozin derivate und deren verwendung - Google Patents

Chinazozin derivate und deren verwendung

Info

Publication number
DE69622148T2
DE69622148T2 DE69622148T DE69622148T DE69622148T2 DE 69622148 T2 DE69622148 T2 DE 69622148T2 DE 69622148 T DE69622148 T DE 69622148T DE 69622148 T DE69622148 T DE 69622148T DE 69622148 T2 DE69622148 T2 DE 69622148T2
Authority
DE
Germany
Prior art keywords
chinazozine
derivatives
chinazozine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69622148T
Other languages
English (en)
Other versions
DE69622148D1 (de
Inventor
Harukazu Fukami
Akiko Ito
Shinjiro Niwata
Saki Kakutani
Motoo Sumida
Yoshinobu Kiso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE69622148D1 publication Critical patent/DE69622148D1/de
Publication of DE69622148T2 publication Critical patent/DE69622148T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65128Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
DE69622148T 1995-09-28 1996-09-27 Chinazozin derivate und deren verwendung Expired - Fee Related DE69622148T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28543795 1995-09-28
JP11655796 1996-05-10
PCT/JP1996/002830 WO1997011941A1 (en) 1995-09-28 1996-09-27 Quinazoline derivatives and use thereof

Publications (2)

Publication Number Publication Date
DE69622148D1 DE69622148D1 (de) 2002-08-08
DE69622148T2 true DE69622148T2 (de) 2002-10-31

Family

ID=26454863

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69622148T Expired - Fee Related DE69622148T2 (de) 1995-09-28 1996-09-27 Chinazozin derivate und deren verwendung

Country Status (6)

Country Link
US (1) US5814631A (de)
EP (1) EP0795548B1 (de)
JP (1) JP3992291B2 (de)
DE (1) DE69622148T2 (de)
ES (1) ES2175127T3 (de)
WO (1) WO1997011941A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003997A1 (fr) 1998-07-15 2000-01-27 Teijin Limited Derives de thiobenzimidazole
US20050267148A1 (en) * 1998-07-15 2005-12-01 Teijin Limited Benzimidazole derivative
WO2000010605A2 (fr) * 1998-08-20 2000-03-02 Senju Pharmaceutical Co., Ltd. Prophylaxie ou remedes pour la perturbation circulatoire de l'oeil
JP2002523404A (ja) * 1998-08-21 2002-07-30 サントリー株式会社 キナゾリン誘導体およびその用途
EP1136488A4 (de) * 1998-12-01 2002-06-12 Meiji Seika Kaisha Sf2809-i, ii, iii. vi, v und vi-verbindungen mit chymase-inhibierender wirkung
JP4556371B2 (ja) * 1999-09-30 2010-10-06 三菱化学株式会社 アシルスルホンアミド誘導体
JP4491866B2 (ja) * 1999-09-30 2010-06-30 三菱化学株式会社 アシルスルホンアミド誘導体
ATE360423T1 (de) * 1999-11-01 2007-05-15 Daiichi Asubio Pharma Co Ltd Verwendung von chymase hemmern gegen vaskuläre lipidablagerung
EP1174151B1 (de) 2000-02-22 2007-01-24 Daiichi Asubio Pharma Co., Ltd. Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
US6500835B2 (en) 2000-02-22 2002-12-31 Suntory Limited Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient
DE60121695T2 (de) * 2000-02-22 2007-08-30 Daiichi Asubio Pharma Co., Ltd. Arzneimittel mit chymaseinhibitoren als wirksames mittel zur behandlung von dermatitis mit zweiphasigen hautreaktionen
AU2001288053A1 (en) * 2000-09-18 2002-03-26 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivatives
US7071220B2 (en) 2000-09-18 2006-07-04 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivatives
CA2442761A1 (en) * 2001-08-24 2003-03-06 Teijin Limited Drugs comprising chymase inhibitors and ace inhibitors as effective ingredients
WO2003078419A1 (en) * 2002-03-15 2003-09-25 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivative
EP1539171A4 (de) * 2002-07-30 2007-12-19 Sod Conseils Rech Applic Verwendung von chymase-hemmern zur prävention und/oder behandlung von arterio-venösem implantatversagen
JP5010917B2 (ja) * 2003-08-29 2012-08-29 エグゼリクシス, インコーポレイテッド c−Kit調節因子および使用方法
US7361767B2 (en) * 2003-11-14 2008-04-22 3M Innovative Properties Company N-sulfonyldicarboximide containing tethering compounds
US7423155B2 (en) 2003-11-14 2008-09-09 3M Innovative Properties Company N-sulfonyldicarboximide containing tethering compounds
NZ554374A (en) * 2004-10-07 2010-11-26 Vitae Pharmaceuticals Inc Diaminoalkane aspartic protease inhibitors
US7544756B2 (en) 2005-09-30 2009-06-09 3M Innovative Properties Company Crosslinked polymers with amine binding groups
EP1956907A2 (de) * 2005-11-25 2008-08-20 Basf Se Cyanobenzolverbindungen für die bekämpfung von tierischen schädlingen
EP2001875A2 (de) * 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase-aktivatoren
US7705034B2 (en) * 2006-10-13 2010-04-27 Hoffmann-La Roche Inc. Vinylogous acid derivatives
EP2188277B1 (de) * 2007-08-16 2012-11-21 Boehringer Ingelheim International GmbH Chinazolindionchymasehemmer
EP2391624B1 (de) 2009-01-30 2013-01-16 Boehringer Ingelheim International GmbH Als chymaseinhibitoren geeignete azachinazolindione
CN103443085B (zh) 2011-03-14 2016-03-23 南京英派药业有限公司 喹唑啉二酮及其应用
TWI527800B (zh) 2011-04-01 2016-04-01 南京英派藥業有限公司 作為聚(二磷酸腺苷酸-核醣)聚合酶(parp)之抑制劑之1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮及其應用
ES2834959T3 (es) 2012-12-06 2021-06-21 Celgene Quanticel Res Inc Inhibidores de histona desmetilasa
MA56473A (fr) 2015-02-16 2022-05-11 The Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy & Undiv Sulfonylurées, composés apparentés, et leur utilisation
US11840543B2 (en) 2017-05-24 2023-12-12 The University Of Queensland Compounds and uses
WO2019008029A1 (en) * 2017-07-07 2019-01-10 Inflazome Limited SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
RS62910B1 (sr) 2017-07-07 2022-03-31 Inflazome Ltd Nova jedinjenja sulfonamid karboksamida
MA49903A (fr) 2017-08-15 2020-06-24 Inflazome Ltd Sulfonylureés et sulfonylthioureés en tant qu'inhibiteurs de nlrp3
US11542255B2 (en) 2017-08-15 2023-01-03 Inflazome Limited Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
US11926600B2 (en) 2017-08-15 2024-03-12 Inflazome Limited Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
CN111094267B (zh) * 2017-09-30 2022-06-14 正大天晴药业集团股份有限公司 作为RORγ抑制剂的磺酰基取代的双环化合物
EP3759077A1 (de) 2018-03-02 2021-01-06 Inflazome Limited Neuartige verbindungen
US11077101B1 (en) * 2018-07-18 2021-08-03 Tango Therapeutics, Inc. Compounds and methods of use
KR20230094196A (ko) 2020-07-31 2023-06-27 탱고 테라퓨틱스, 인크. Mtap-결핍 및/또는 mta 축적 암의 치료에 유용한 피페리딘-1-일-n-피리딘-3-일-2-옥소아세트아마이드 유도체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684654A (en) * 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
IL79249A (en) * 1986-06-26 1992-02-16 Makhteshim Chem Works Ltd Herbicidal compositions containing haloalkylthioquinazoline di(thi)ones and some new such compounds

Also Published As

Publication number Publication date
JP3992291B2 (ja) 2007-10-17
EP0795548A4 (de) 1998-09-02
ES2175127T3 (es) 2002-11-16
EP0795548B1 (de) 2002-07-03
US5814631A (en) 1998-09-29
EP0795548A1 (de) 1997-09-17
DE69622148D1 (de) 2002-08-08
WO1997011941A1 (en) 1997-04-03

Similar Documents

Publication Publication Date Title
DE69622148D1 (de) Chinazozin derivate und deren verwendung
DE69736994D1 (de) Ionische Malonsäuredinitril Derivate und deren Verwendung
DE873126T1 (de) Markierte vitamin d-verbindungen und deren verwendung
DE69617236D1 (de) N-heteroaryl-pyridinsulfonamidderivate und deren verwendung als endothelinantagonisten
DE59711847D1 (de) Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung
DE69620982D1 (de) Polyalkylensuccinimide und deren nachbehandelte Derivate
DE59506234D1 (de) Pigmentzubereitung und deren Verwendung
DE69535171D1 (de) Poly-perfluoroalkylsubstituierte Alkohole und Säuren, und deren Derivate
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
ATE224910T1 (de) Derivate von dolestatin, deren herstellung und verwendung
DE59802439D1 (de) Spiroverbindungen und deren verwendung
DE69123915T2 (de) Indol-Verbindungen und deren Verwendung
DE69620270D1 (de) Backfett und dessen Verwendung
ATE225342T1 (de) Benzofuran-derivate und deren verwendung
DE69513307T4 (de) Zusammensetzung und verwendung
DE69729570D1 (de) Fotpempfindliche zusammensetzung und deren verwendung
DE69632678D1 (de) Harzzusammensetzung und deren verwendung
DE69713512D1 (de) Substituierte phtalocyanine und deren verwendung
DE69835007D1 (de) Entkoffeinierte mate-extrakte und deren verwendung
DE59300501D1 (de) Verbesserte Intumeszenzträger und deren Verwendung.
DE59810405D1 (de) Spiroverbindungen und deren verwendung
DE69600829T2 (de) Mikrobizide Zusammensetzung und deren Verwendung
ATE215061T1 (de) ((3-alkoxy-phenoxy)-ethyl)-dialkylaminderivate und deren verwendung als lokalanaesthetika
DE69522233T2 (de) Konjugierte n-fluorpyridinium salzpolymere und deren verwendung
DE59906951D1 (de) Spiroverbindungen und deren verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP

8339 Ceased/non-payment of the annual fee